ExploreWatchlistsPricing
  1. JP-listed companies
  2. MIZUHO MEDY CO.,LTD.
  3. Financials
  4. Total assets

MIZUHO MEDY CO.,LTD. (4595)

Market cap
¥35.2B
P/E ratio
10.9x
Mizuho Medic develops and manufactures diagnostic test kits for hospitals and consumers, specializing in infectious disease testing including COVID-19 and influenza.
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndTotal assets (Million JPY)YoY (%)
Dec 31, 202522,375+7.94%
Dec 31, 202420,729+9.40%
Dec 31, 202318,948-0.81%
Dec 31, 202219,102+56.66%
Dec 31, 202112,193+101.48%
Dec 31, 20206,052-4.94%
Dec 31, 20196,367+14.04%
Dec 31, 20185,583+27.53%
Dec 31, 20174,378+8.31%
Dec 31, 20164,042+15.80%
Dec 31, 20153,491+8.48%
Dec 31, 20143,218

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat